Anzeige
Mehr »
Mittwoch, 01.04.2026 - Börsentäglich über 12.000 News
Rohstoff-Boom trifft Rekord-Bohrungen: Steht diese Aktie vor der nächsten Rally?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Insider Monkey

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
MoUpstart Holdings, Inc. (UPST) Rating Raised by BTIG as Bank Charter Could Reduce Funding Risk
MoBMO Highlights Alaska Air Group, Inc. (ALK) Earnings Expansion Potential Despite Fuel Cost Uncertainty
MoOrla Mining Ltd. (ORLA) Reports Q4 Revenue of $378.5M, Up From $92.8M YoY
MoBioMarin Pharmaceutical Inc. (BMRN) Rated Overweight at Wells Fargo Despite Voxzogo Phase 2 Study Discontinuations
MoVEON Ltd. (VEON)'s Uklon Launches Travel Service for Domestic and International Bus Ticket Booking
Mo10 Best Penny Stocks That Could Triple Your Money
MoWhy Bullish Analysts Still See Major Upside in Gossamer Bio (GOSS) After PROSERA Setback
MoAnalyst Initiates Sanofi (SNY) with 'Outperform' Rating
MoRio Tinto Gets A$2 Billion Government Support to Keep Boyne Smelter Running
MoBlackstone-Backed Consortium Acquires Indian Cricket Franchise
MoTrump Administration to Pay TotalEnergies $1B to Abandon Wind Farms
MoEni (E) Announces Bump in Shareholder Returns
MoBristol-Myers Squibb Gets FDA Approval for Hodgkin's Lymphoma Treatment
MoBP Upgraded to 'Overweight', Price Target Raised to $49.40
Mo13 Best Stocks to Invest In on Robinhood for Beginners
SoWhy Rocket Pharmaceuticals (RCKT) Got a Commercial Boost From FDA Approval of KRESLADI
SoWhy Vertical Aerospace (EVTL) Is Expanding Its Valo Supplier Network Ahead of Certification
SoWhy UBS Started Jasper Therapeutics (JSPR) at Neutral Despite Progress in Briquilimab
SoWhy Rezolve AI (RZLV) Is Betting Big on Reward Loyalty to Scale Commerce Media and Payments
SoWhy Allogene Therapeutics (ALLO) Says Its Lead Cancer Program Is Still on Track in 2026
SoWhy BTIG Cut Its Target on Humacyte (HUMA) but Kept a Bullish View on the Bigger Opportunity
SoWhy Aardvark Therapeutics (AARD) Paused Late-Stage ARD-101 Trials After Cardiac Findings
SoACM Research (ACMR) Shanghai Unit Outlines Profit Distribution Plan For Fiscal 2025
SoAlphabet Inc. (GOOGL) And Meta Lost a Case in Los Angeles, Here's What You Should Know
SoUBS Lowers PT on Microsoft (MSFT), Maintains a Buy Rating